Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 7, 2020

View Archived Issues

MTX-COVAB shows potent therapeutic and prophylactic activity in mode of advanced COVID-19

Enrollment ongoing in phase I study of BAY-1211163 in ARDS

Precision BioSciences reports interim phase I/II data on PBCAR-0191

AstraZeneca initiates first-in-human phase I study of AZD-3427

Lilly and UnitedHealth collaborate on pragmatic study of bamlanivimab for COVID-19

Interim analysis supports continuation of phase II/III GAIN trial of atuzaginstat in AD

CC Biotech describes new polypeptides for treating bacterial infections

New MAPK 1 inhibitors identified at Medshine Discovery

Ascentawits Pharmaceuticals discovers AKR1C3-activatable DNA alkylating drugs

Jiangsu Hansoh Pharmaceutical, Shanghai Hansoh Biomedical patent RET inhibitors

New IDO-1 inhibitors synthesized at Hutchison MediPharma

mRNA SARS-CoV-2 vaccines to usher in 'golden age of vaccinology'

Kinase inhibitor for hearing loss protection

Data from phase II studies of VAL-083 in glioblastoma

FDA approves Saxenda to treat obesity in adolescents

Preliminary activity seen with ianalumab plus ibrutinib in relapsed/refractory CLL

Phase III study of maribavir to treat transplant recipients for CMV infection meets primary endpoint

FDA approves IND for Alligator's mitazalimab

Early phase I results show AVID-200 is well tolerated in myelofibrosis patients

HOOKIPA reports interim phase I data on HB-201 for HPV16+ cancers

New vulnerability in "KL" KRAS subtype

DoD grant to support evaluation of BXCL-501 for PTSD

FDA places clinical hold on phase I/II study of BPX-601

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...